Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), a progressive paralytic disease characterized by loss of motor neurons. With the use of mice carrying a deletable mutant gene, expression within motor neurons was shown to be a primary determinant of disease onset and of an early phase of disease progression. Diminishing the mutant levels in microglia had little effect on the early disease phase but sharply slowed later disease progression. Onset and progression thus represent distinct disease phases defined by mutant action within different cell types to generate non–cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“accumulation of mutant SOD1 in microglia may further amplify their proinflammatory and neurotoxic activity (149, 150).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [150]
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Self-citationUNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Self-citationWild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Self-citation
Research works printed but not linked: 2
- T. Kawamata, H. Akiyama, T. Yamada, P. L. McGeer, Am. J. Pathol.140, 691 (1992).
- A. Mazzone, G. Ricevuti, Haematologica80, 161 (1995).
Cited by
Items 201–300 of 1,001
Rossi, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.04.003 · Cited by 177
Da Cruz, S., Parone, P. A., Lopes, V. S., Lillo, C., McAlonis-Downes, M., Lee, S. K., Vetto, A. P., Petrosyan, S., Marsala, M., Murphy, A. N., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.019 · Cited by 177
Self-citationParone, P. A., Da Cruz, S., Han, J. S., McAlonis-Downes, M., Vetto, A. P., Lee, S. K., Tseng, E., & Cleveland, D. W. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1119-12.2013 · Cited by 177
Self-citationInflammation and neurovascular changes in amyotrophic lateral sclerosis
Evans, M. C., Couch, Y., Sibson, N., & Turner, M. R. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.008 · Cited by 176
Zhong, Z., Ilieva, H., Hallagan, L., Bell, R., Singh, I., Paquette, N., Thiyagarajan, M., Deane, R., Fernandez, J. A., Lane, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38476 · Cited by 176
Self-citationCharacterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes
Zhao, W., Beers, D. R., Hooten, K. G., Sieglaff, D. H., Zhang, A., Kalyana-Sundaram, S., Traini, C. M., Halsey, W. S., Hughes, A. M., Sathe, G. M., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0357 · Cited by 176
Sheean, R. K., McKay, F. C., Cretney, E., Bye, C. R., Perera, N. D., Tomas, D., Weston, R. A., Scheller, K. J., Djouma, E., Menon, P., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0035 · Cited by 173
The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172
“[126–128,133] [130,135] [131,133] [132,136] [137,138] No”
Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia
Xiao, Q., Zhao, W., Beers, D. R., Yen, A. A., Xie, W., Henkel, J. S., & Appel, S. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04677.x · Cited by 174
“Boillee et al. (2006) used the Cre-Lox system to document that reducing mSOD1 expression in mSOD1G37R microglia also resulted in longer disease duration and survival in ALS mice.”
MethodFrom bone marrow to microglia: barriers and avenues
Davoust, N., Vuaillat, C., Androdias, G., & Nataf, S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.01.010 · Cited by 174
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
Kawamata, H., & Manfredi, G. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.05.003 · Cited by 173
Garofalo, S., Cocozza, G., Porzia, A., Inghilleri, M., Raspa, M., Scavizzi, F., Aronica, E., Bernardini, G., Peng, L., Ransohoff, R. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15644-8 · Cited by 170
Intercellular (Mis)communication in Neurodegenerative Disease
Garden, G. A., & La Spada, A. R. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.017 · Cited by 170
Exosomes: Origins and Therapeutic Potential for Neurodegenerative Disease
Sarko, D. K., & McKinney, C. E. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00082 · Cited by 170
Lieberman, A. P., Yu, Z., Murray, S., Peralta, R., Low, A., Guo, S., Yu, X. X., Cortes, C. J., Bennett, C. F., Monia, B. P., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.008 · Cited by 169
Li, Q., Vande Velde, C., Israelson, A., Xie, J., Bailey, A. O., Dong, M.-Q., Chun, S.-J., Roy, T., Winer, L., Yates, J. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014862107 · Cited by 169
Self-citationCortes, C. J., Ling, S.-C., Guo, L. T., Hung, G., Tsunemi, T., Ly, L., Tokunaga, S., Lopez, E., Sopher, B. L., Bennett, C. F., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.001 · Cited by 166
Self-citationAggregation of Copper–Zinc Superoxide Dismutase in Familial and Sporadic ALS
Chattopadhyay, M., & Valentine, J. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2536 · Cited by 163
“Although nonmotor neuronal cells participate in the ALS disease mechanism (12), selective expression of mutant SOD1 in motor neurons is sufficient to induce ALS-like symptoms in mice, suggesting that SOD1 aggregation in motor neurons plays a major role in their eventual demise (37).”
A Drosophila Model for Amyotrophic Lateral Sclerosis Reveals Motor Neuron Damage by Human SOD1
Watson, M. R., Lagow, R. D., Xu, K., Zhang, B., & Bonini, N. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804817200 · Cited by 163
Innate immune activation in neurodegenerative diseases
Castro-Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 162
The microglial component of amyotrophic lateral sclerosis
Clarke, B. E., & Patani, R. (2020) · Brain · doi:10.1093/brain/awaa309 · Cited by 164
MiR-155: An Important Regulator of Neuroinflammation
Zingale, V. D., Gugliandolo, A., & Mazzon, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010090 · Cited by 163
RNA-binding proteins with prion-like domains in ALS and FTLD-U
Gitler, A. D., & Shorter, J. (2011) · Prion · doi:10.4161/pri.5.3.17230 · Cited by 161
Dodge, J. C., Haidet, A. M., Yang, W., Passini, M. A., Hester, M., Clarke, J., Roskelley, E. M., Treleaven, C. M., Rizo, L., Martin, H., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.60 · Cited by 160
Miller, T. M., Kim, S. H., Yamanaka, K., Hester, M., Umapathi, P., Arnson, H., Rizo, L., Mendell, J. R., Gage, F. H., Cleveland, D. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609411103 · Cited by 160
Self-citationPrion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain
Pearce, M. M. P., Spartz, E. J., Hong, W., Luo, L., & Kopito, R. R. (2015) · Nature Communications · doi:10.1038/ncomms7768 · Cited by 159
Prostaglandin signaling suppresses beneficial microglial function in Alzheimer’s disease models
Johansson, J. U., Woodling, N. S., Wang, Q., Panchal, M., Liang, X., Trueba-Saiz, A., Brown, H. D., Mhatre, S. D., Loui, T., & Andreasson, K. I. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77487 · Cited by 161
Johnson, F. O., & Atchison, W. D. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.07.010 · Cited by 159
Cheroni, C., Marino, M., Tortarolo, M., Veglianese, P., De Biasi, S., Fontana, E., Zuccarello, L. V., Maynard, C. J., Dantuma, N. P., & Bendotti, C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn319 · Cited by 159
Glia in the pathogenesis of neurodegenerative diseases
Verkhratsky, A., Parpura, V., Pekna, M., Pekny, M., & Sofroniew, M. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140107 · Cited by 141
NF‐κB activation in astrocytes drives a stage‐specific beneficial neuroimmunological response in ALS
Ouali Alami, N., Schurr, C., Olde Heuvel, F., Tang, L., Li, Q., Tasdogan, A., Kimbara, A., Nettekoven, M., Ottaviani, G., Raposo, C., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798697 · Cited by 157
Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156
Soon, C. P. W., Donnelly, P. S., Turner, B. J., Hung, L. W., Crouch, P. J., Sherratt, N. A., Tan, J., Lim, N. K.-H., Lam, L. Q., Bica, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274407 · Cited by 166
Peripheral monocytes are functionally altered and invade the CNS in ALS patients
Zondler, L., Müller, K., Khalaji, S., Bliederhäuser, C., Ruf, W. P., Grozdanov, V., Thiemann, M., Fundel-Clemes, K., Freischmidt, A., Holzmann, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1548-y · Cited by 154
“Regarding the more progressed disease, several groups have shown that Iba1+ pro-inflammatory microglia accelerate neurodegeneration during the progressive phase of the disease [5, 8, 14, 36, 43], thereby possibly abrogating the protective effect of peripheral monocyte-derived cells.”
BackgroundShi, J., Johansson, J., Woodling, N. S., Wang, Q., Montine, T. J., & Andreasson, K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903487 · Cited by 152
Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis
Shang, Y., & Huang, E. J. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.036 · Cited by 154
Pereira, J. D., DuBreuil, D. M., Devlin, A.-C., Held, A., Sapir, Y., Berezovski, E., Hawrot, J., Dorfman, K., Chander, V., & Wainger, B. J. (2021) · Nature Communications · doi:10.1038/s41467-021-24776-4 · Cited by 150
Axonal Degeneration in Motor Neuron Disease
Fischer, L. R., & Glass, J. D. (2007) · Neurodegenerative Diseases · doi:10.1159/000107704 · Cited by 152
There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS
Gitler, A. D., & Tsuiji, H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.004 · Cited by 151
Gowing, G., Philips, T., Van Wijmeersch, B., Audet, J.-N., Dewil, M., Van Den Bosch, L., Billiau, A. D., Robberecht, W., & Julien, J.-P. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3494-08.2008 · Cited by 148
Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD
Pineda, S. S., Lee, H., Ulloa-Navas, M. J., Linville, R. M., Garcia, F. J., Galani, K., Engelberg-Cook, E., Castanedes, M. C., Fitzwalter, B. E., Pregent, L. J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.031 · Cited by 144
Ontogeny and Functions of Central Nervous System Macrophages
Katsumoto, A., Lu, H., Miranda, A. S., & Ransohoff, R. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400716 · Cited by 149
“Similarly, deletion of mSOD specifically from CD11b myeloid cells extended the survival of mice significantly, particularly during the late phase of disease (79).”
BackgroundSOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS
Hayashi, Y., Homma, K., & Ichijo, H. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.10.006 · Cited by 174
Takeuchi, H., Mizoguchi, H., Doi, Y., Jin, S., Noda, M., Liang, J., Li, H., Zhou, Y., Mori, R., Yasuoka, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021108 · Cited by 148
Self-citationMutant huntingtin impairs immune cell migration in Huntington disease
Kwan, W., Träger, U., Davalos, D., Chou, A., Bouchard, J., Andre, R., Miller, A., Weiss, A., Giorgini, F., Cheah, C., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64484 · Cited by 148
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
Staff, N. P., Jones, D. T., & Singer, W. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.001 · Cited by 150
Cre Driver Mice Targeting Macrophages
Shi, J., Hua, L., Harmer, D., Li, P., & Ren, G. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7837-3_24 · Cited by 145
Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers
Vahsen, B. F., Gray, E., Thompson, A. G., Ansorge, O., Anthony, D. C., Cowley, S. A., Talbot, K., & Turner, M. R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00487-8 · Cited by 147
Blood-CNS Barrier Impairment in ALS patients versus an animal model
Garbuzova-Davis, S., & Sanberg, P. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00021 · Cited by 146
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
Gallardo, G., Schlüter, O. M., & Südhof, T. C. (2008) · Nature Neuroscience · doi:10.1038/nn2058 · Cited by 145
Redox modifier genes in amyotrophic lateral sclerosis in mice
Marden, J. J., Harraz, M. M., Williams, A. J., Nelson, K., Luo, M., Paulson, H., & Engelhardt, J. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31265 · Cited by 145
Duvick, L., Barnes, J., Ebner, B., Agrawal, S., Andresen, M., Lim, J., Giesler, G. J., Zoghbi, H. Y., & Orr, H. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.022 · Cited by 145
Role of microglia in neuronal degeneration and regeneration
Walter, L. M., & Neumann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0180-5 · Cited by 167
Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration
Henstridge, C. M., Tzioras, M., & Paolicelli, R. C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00063 · Cited by 143
Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration
Elrick, M. J., Pacheco, C. D., Yu, T., Dadgar, N., Shakkottai, V. G., Ware, C., Paulson, H. L., & Lieberman, A. P. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp552 · Cited by 142
Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice
Ito, Y., Yamada, M., Tanaka, H., Aida, K., Tsuruma, K., Shimazawa, M., Hozumi, I., Inuzuka, T., Takahashi, H., & Hara, H. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.08.013 · Cited by 141
Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129037 · Cited by 140
The past, present and future of stem cell clinical trials for ALS
Thomsen, G. M., Gowing, G., Svendsen, S. P., & Svendsen, C. N. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.02.021 · Cited by 151
What is microglia neurotoxicity (Not)?
Biber, K., Owens, T., & Boddeke, E. (2014) · Glia · doi:10.1002/glia.22654 · Cited by 140
Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis
Appel, S. H., Engelhardt, J. I., Henkel, J. S., Siklos, L., Beers, D. R., Yen, A. A., Simpson, E. P., Luo, Y., Carrum, G., Heslop, H. E., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000327668.43541.22 · Cited by 140
Oxidized/misfolded superoxide dismutase‐1: the cause of all amyotrophic lateral sclerosis?
Kabashi, E., Valdmanis, P. N., Dion, P., & Rouleau, G. A. (2007) · Annals of Neurology · doi:10.1002/ana.21319 · Cited by 139
Scekic‐Zahirovic, J., Oussini, H. E., Mersmann, S., Drenner, K., Wagner, M., Sun, Y., Allmeroth, K., Dieterle, S., Sinniger, J., Dirrig‐Grosch, S., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1687-9 · Cited by 162
Goulay, R., Romo, L. M., Hol, E. M., & Dijkhuizen, R. M. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00755-2 · Cited by 159
Lobsiger, C. S., Boillée, S., & Cleveland, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702230104 · Cited by 140
Self-citationAmyotrophic lateral sclerosis models and human neuropathology: similarities and differences
Kato, S. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0308-4 · Cited by 168
Oeckl, P., Weydt, P., Steinacker, P., Anderl-Straub, S., Nordin, F., Volk, A. E., Diehl-Schmid, J., Andersen, P. M., Kornhuber, J., Danek, A., et al. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318868 · Cited by 139
Humphrey, J., Venkatesh, S., Hasan, R., Herb, J. T., de Paiva Lopes, K., Küçükali, F., Byrska-Bishop, M., Evani, U. S., Narzisi, G., Fagegaltier, D., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01205-3 · Cited by 138
Amyotrophic lateral sclerosis: Problems and prospects
Sreedharan, J., & Brown, R. H. (2013) · Annals of Neurology · doi:10.1002/ana.24012 · Cited by 138
Konishi, H., Kobayashi, M., Kunisawa, T., Imai, K., Sayo, A., Malissen, B., Crocker, P. R., Sato, K., & Kiyama, H. (2017) · Glia · doi:10.1002/glia.23204 · Cited by 137
Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration
Ising, C., & Heneka, M. T. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0153-x · Cited by 128
Corti, S., Locatelli, F., Papadimitriou, D., Del Bo, R., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Fortunato, F., Strazzer, S., et al. (2007) · Brain · doi:10.1093/brain/awm043 · Cited by 137
The role of microglia in human disease: therapeutic tool or target?
Cartier, N., Lewis, C.-A., Zhang, R., & Rossi, F. M. V. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1330-y · Cited by 136
Wang, L., Popko, B., Tixier, E., & Roos, R. P. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.010 · Cited by 132
Gifondorwa, D. J., Robinson, M. B., Hayes, C. D., Taylor, A. R., Prevette, D. M., Oppenheim, R. W., Caress, J., & Milligan, C. E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4057-07.2007 · Cited by 135
Pinto, S., Cunha, C., Barbosa, M., Vaz, A. R., & Brites, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00273 · Cited by 135
Inflammatory aspects of Alzheimer’s disease
Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 164
Astrogliosis in Amyotrophic Lateral Sclerosis: Role and Therapeutic Potential of Astrocytes
Vargas, M. R., & Johnson, J. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.012 · Cited by 133
Bennett, S. A., Tanaz, R., Cobos, S. N., & Torrente, M. P. (2019) · Translational Research · doi:10.1016/j.trsl.2018.10.002 · Cited by 130
Inflammation in ALS and SMA: Sorting out the good from the evil
Papadimitriou, D., Le Verche, V., Jacquier, A., Ikiz, B., Przedborski, S., & Re, D. B. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.005 · Cited by 132
Kanouchi, T., Ohkubo, T., & Yokota, T. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301826 · Cited by 134
D'Ambrosi, N., Finocchi, P., Apolloni, S., Cozzolino, M., Ferri, A., Padovano, V., Pietrini, G., Carrì, M. T., & Volonté, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901212 · Cited by 131
“studies indeed demonstrated that ALS-linked microglia contribute to motoneuron death and promote disease progression (8, 35).”
BackgroundThe unfolded protein response in familial amyotrophic lateral sclerosis
Wang, L., Popko, B., & Roos, R. P. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq546 · Cited by 132
Pitzer, C., Krüger, C., Plaas, C., Kirsch, F., Dittgen, T., Müller, R., Laage, R., Kastner, S., Suess, S., Spoelgen, R., et al. (2008) · Brain · doi:10.1093/brain/awn243 · Cited by 129
Amyotrophic lateral sclerosis: A neurovascular disease
Garbuzova-Davis, S. N., Rodrigues, M. C. O., Hernandez‐Ontiveros, D. G., Louis, M. K., Willing, A. E., Borlongan, C. V., & Sanberg, P. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.049 · Cited by 142
Cytoprotective protein C pathways and implications for stroke and neurological disorders
Zlokovic, B. V., & Griffin, J. H. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.01.005 · Cited by 128
Apolloni, S., Parisi, C., Pesaresi, M. G., Rossi, S., Carrì, M. T., Cozzolino, M., Volonté, C., & D’Ambrosi, N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203262 · Cited by 128
The brain’s best friend: microglial neurotoxicity revisited
Hellwig, S., Heinrich, A., & Biber, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00071 · Cited by 126
Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production
Wang, B., Rao, Y.-H., Inoue, M., Hao, R., Lai, C.-H., Chen, D., McDonald, S. L., Choi, M.-C., Wang, Q., Shinohara, M. L., et al. (2014) · Nature Communications · doi:10.1038/ncomms4479 · Cited by 127
Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis
Harten, A. C. M. V., Phatnani, H. P., & Przedborski, S. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.04.008 · Cited by 136
Prow, N. A., & Irani, D. N. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05230.x · Cited by 126
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
“In contrast, specific deletion of mutant hSOD1 transgene in the myeloid lineage (targeting both microglia and macrophages) or in astrocytes does not alter disease onset, but slows disease progression and increases life span (Boillee et al., 2006; Yamanaka et al., 2008).”
BackgroundWatanabe, S., Kaneko, K., & Yamanaka, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.433615 · Cited by 125
Self-citationDifferential contribution of microglia and monocytes in neurodegenerative diseases
Baufeld, C., O’Loughlin, E., Calcagno, N., Madore, C., & Butovsky, O. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1795-7 · Cited by 123
Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS
Martineau, É., Di Polo, A., Vande Velde, C., & Robitaille, R. (2018) · eLife · doi:10.7554/elife.41973 · Cited by 120
Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model
Gonzalez de Aguilar, J.-L., Niederhauser-Wiederkehr, C., Halter, B., De Tapia, M., Di Scala, F., Demougin, P., Dupuis, L., Primig, M., Meininger, V., & Loeffler, J.-P. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00017.2007 · Cited by 124
Gu, X., André, V. M., Cepeda, C., Li, S.-H., Li, X.-J., Levine, M. S., & Yang, X. W. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-8 · Cited by 123
Kir4.1-Dependent Astrocyte-Fast Motor Neuron Interactions Are Required for Peak Strength
Kelley, K. W., Ben Haim, L., Schirmer, L., Tyzack, G. E., Tolman, M., Miller, J. G., Tsai, H.-H., Chang, S. M., Molofsky, A. V., Yang, Y., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.010 · Cited by 122
Chiot, A., Zaïdi, S., Iltis, C., Ribon, M., Berriat, F., Schiaffino, L., Jolly, A., de la Grange, P., Mallat, M., Bohl, D., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00718-z · Cited by 122
Self-citationTakeuchi, H., & Suzumura, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00189 · Cited by 121
Lepore, A. C., Haenggeli, C., Gasmi, M., Bishop, K. M., Bartus, R. T., Maragakis, N. J., & Rothstein, J. D. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.034 · Cited by 134
Metadata
- Authors
- Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W.
- Affiliations
- Ludwig Institute for Cancer Research and Departments of Medicine and Neuroscience, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- ORCID
- Venue
- Science
- Published
- 2006-06-02
- Volume
- 312
- Issue
- 5778
- Pages
- 1389-1392
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2033158384
- Cited by
- 1,623
- References
- 28
- Citations by year
- 2026: 42 · 2025: 40 · 2024: 52 · 2023: 59 · 2022: 69 · 2021: 60 · 2020: 95 · 2019: 82 · 2018: 74 · 2017: 84 · 2016: 82 · 2015: 81 · 2014: 109 · 2013: 107 · 2012: 115
- FWCI
- 66.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 27036, R37NS027036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, motor neurons, microglia, disease onset, disease progression, cell replacement therapy, mouse model
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Motor Neurons, Mutation, Superoxide Dismutase, Microglia, Disease Progression, Integrases, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.